News | February 27, 2024
Shilpa Medicare gets Europe approval for Varenicline Tablets, 0.5mg and 1mg
Varenicline is indicated for smoking cessation in adults
Varenicline is indicated for smoking cessation in adults
The acquisition will build on AstraZeneca’s expertise in respiratory syncytial virus
The new tests can support clinical decision making when prescribing direct oral anticoagulants for stroke prevention
About 75% of all primary liver cancers in adults are HCC and up to 30% of HCC patients are eligible for embolisation
Approval based on a separate phase III trial among Chinese patients reinforcing mepolizumab’s efficacy and safety data
Submission based on positive results from global phase 3 study demonstrating overall survival benefit of TIVDAK over chemotherapy
Dapagliflozin and Saxagliptin Tablets (RLD Qtern) had estimated annual sales of US $5 million in the US
The company has received five final approvals
US FDA approval based on NEURO-TTRansform Phase III results
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
Subscribe To Our Newsletter & Stay Updated
